Test IVD tehotenský Care Viola Early C Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

test ivd tehotenský care viola early c

care diagnostica gmbh römerstrasse 8 a2513 möllersdorf rakúsko -

Test tehotenský Predictor EARLY Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

test tehotenský predictor early

omega teknika the crescent building, northwood office park dublin 9 Írsko -

Médium kultivačné Complete Early Cleavage Medium (ECM) with Dextran Serum Supplement (DSS) Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

médium kultivačné complete early cleavage medium (ecm) with dextran serum supplement (dss)

fujifilm irvine scientific, inc. 2511 daimler street ca 92705 santa ana spojené štáty americké -

Médium kultivačné s gentamicínom Early Cleavage Medium (ECM) Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

médium kultivačné s gentamicínom early cleavage medium (ecm)

fujifilm irvine scientific, inc. 2511 daimler street ca 92705 santa ana spojené štáty americké -

Test tehotenský Early pregnancy test Lifecare Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

test tehotenský early pregnancy test lifecare

core technology co., ltd. room 100, c building, no.29 life park rd., changping district 102206 beijing Čína -

Phesgo Európska únia - slovenčina - EMA (European Medicines Agency)

phesgo

roche registration gmbh - pertuzumab, trastuzumab - neoplazmy prsníkov - antineoplastické činidlá - early breast cancer (ebc)phesgo is indicated for use in combination with chemotherapy in:the neoadjuvant treatment of adult patients with her2-positive, locally advanced, inflammatory, or early stage breast cancer at high risk of recurrencethe adjuvant treatment of adult patients with her2-positive early breast cancer at high risk of recurrencemetastatic breast cancer (mbc)phesgo is indicated for use in combination with docetaxel in adult patients with her2-positive metastatic or locally recurrent unresectable breast cancer, who have not received previous anti-her2 therapy or chemotherapy for their metastatic disease.

Verzenios Európska únia - slovenčina - EMA (European Medicines Agency)

verzenios

eli lilly nederland b.v. - abemaciclib - neoplazmy prsníkov - antineoplastické činidlá - early breast cancerverzenios in combination with endocrine therapy is indicated for the adjuvant treatment of adult patients with hormone receptor (hr) positive, human epidermal growth factor receptor 2 (her2) negative, node positive early breast cancer at high risk of recurrence (see section 5. in pre or perimenopausal women, aromatase inhibitor endocrine therapy should be combined with a luteinising hormone-releasing hormone (lhrh) agonist. advanced or metastatic breast cancerverzenios is indicated for the treatment of women with hormone receptor (hr) positive, human epidermal growth factor receptor 2 (her2) negative locally advanced or metastatic breast cancer in combination with an aromatase inhibitor or fulvestrant as initial endocrine-based therapy, or in women who have received prior endocrine therapy. in pre- or perimenopausal women, the endocrine therapy should be combined with a lhrh agonist.

Bisoprolol Medreg 10 mg Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

bisoprolol medreg 10 mg

medreg s.r.o., Česká republika - bisoprolol - 41 - cardiaca

Bisoprolol Medreg 5 mg Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

bisoprolol medreg 5 mg

medreg s.r.o., Česká republika - bisoprolol - 41 - cardiaca

Bisoprolol Medreg 2,5 mg Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

bisoprolol medreg 2,5 mg

medreg s.r.o., Česká republika - bisoprolol - 41 - cardiaca